Stay updated on Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study record now shows recruitment is closed with a 'No longer looking for participants' status. It also includes a new revision (v3.6.0) dated 2026-06-11, while the prior revision (v3.5.5) from 2026-03-11 was removed.SummaryDifference0.9%

- Check20 days agoChange DetectedThis change adds a new revision entry v3.5.5 and removes the previous v3.5.4 in the study record history, reflecting an incremental update to the page’s version history.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry labeled v3.5.4 was added to the history and the previous v3.5.3 entry was removed, updating the page's revision metadata.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s software/version revision indicator was updated from v3.5.2 to v3.5.3, reflecting a general release-level change rather than an update to the trial history or study details.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the record history.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision: v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs. Chemo in Advanced NSCLC Clinical Trial page.